Skip to main content
. 2022 Jan 24;14:17588359211070643. doi: 10.1177/17588359211070643

Table 1.

Summary of patient characteristics (N = 41).

Patient characteristic Total %
Age, years <65 23 56.10
⩾65 18 43.90
Gender Male 26 63.41
Female 15 36.59
Primary tumor site Right 12 29.27
Left 14 34.15
Rectum 14 34.15
Transverse colon 1 2.44
Extent of metastatic disease non-LLD 27 65.85
LLD 14 34.15
First-line regimen XELOX 3 7.32
FOLFOX 19 46.34
FOLFOX-Bev 8 19.51
FOLFOX-Cet 5 12.20
FOLFIRI 2 4.88
FOLFIRI-Bev 3 7.32
FOLFIRI-Cet 1 2.44
Response rate PR 22 53.66
SD 11 26.83
PD 8 19.51